SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 235.68 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 591.48 |
| Book Value / Share | 3.74 |
| Price / Book | n/a |
| NCAV ($M) | -231.66 |
| NCAV / Share | -1.46 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.43 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.94 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.58 |
| Current Ratio | 3.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 341.08 |
| Assets | 1,164.22 |
| Liabilities | 572.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,041,010 | 17,067,041 | 35.40 | |
| 5,822,787 | 15,729,304 | 37.02 | |
| 1,907,574 | 5,744,518 | 33.21 | |
| 1,188,001 | 3,861,172 | 30.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BPMC – Blueprint Medicines Corporation | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. |